

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 5.61246861 |
| 2 | pentose-phosphate shunt (GO:0006098) | 4.47319007 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.25331932 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.25331932 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 4.17216430 |
| 6 | NADPH regeneration (GO:0006740) | 4.13151259 |
| 7 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.01549338 |
| 8 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.88992485 |
| 9 | NADH metabolic process (GO:0006734) | 3.86681763 |
| 10 | metallo-sulfur cluster assembly (GO:0031163) | 3.85946455 |
| 11 | iron-sulfur cluster assembly (GO:0016226) | 3.85946455 |
| 12 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.79585714 |
| 13 | regulation of mitochondrial translation (GO:0070129) | 3.72912002 |
| 14 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.71360125 |
| 15 | nuclear envelope reassembly (GO:0031468) | 3.69903360 |
| 16 | mitotic nuclear envelope reassembly (GO:0007084) | 3.69903360 |
| 17 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.69419403 |
| 18 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.69419403 |
| 19 | establishment of viral latency (GO:0019043) | 3.67048546 |
| 20 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.65882132 |
| 21 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.65882132 |
| 22 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.65882132 |
| 23 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.65459480 |
| 24 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.65459480 |
| 25 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.60946891 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.60771757 |
| 27 | L-phenylalanine metabolic process (GO:0006558) | 3.60771757 |
| 28 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.59722586 |
| 29 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.59672452 |
| 30 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.57227724 |
| 31 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.57227724 |
| 32 | protein deneddylation (GO:0000338) | 3.56504396 |
| 33 | cullin deneddylation (GO:0010388) | 3.54843575 |
| 34 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.50460856 |
| 35 | GDP-mannose metabolic process (GO:0019673) | 3.49596618 |
| 36 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.47626910 |
| 37 | galactose catabolic process (GO:0019388) | 3.46928190 |
| 38 | valine metabolic process (GO:0006573) | 3.46921441 |
| 39 | oxidative phosphorylation (GO:0006119) | 3.38705930 |
| 40 | positive regulation of ligase activity (GO:0051351) | 3.35679683 |
| 41 | ATP synthesis coupled proton transport (GO:0015986) | 3.35605138 |
| 42 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.35605138 |
| 43 | nucleoside salvage (GO:0043174) | 3.34475444 |
| 44 | establishment of integrated proviral latency (GO:0075713) | 3.32482422 |
| 45 | tricarboxylic acid cycle (GO:0006099) | 3.30223682 |
| 46 | cysteine metabolic process (GO:0006534) | 3.29361673 |
| 47 | DNA deamination (GO:0045006) | 3.27424348 |
| 48 | ubiquinone biosynthetic process (GO:0006744) | 3.23953255 |
| 49 | quinone biosynthetic process (GO:1901663) | 3.23953255 |
| 50 | purine nucleotide salvage (GO:0032261) | 3.21367835 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.19502286 |
| 52 | L-phenylalanine catabolic process (GO:0006559) | 3.19502286 |
| 53 | protein targeting to mitochondrion (GO:0006626) | 3.19301863 |
| 54 | GMP metabolic process (GO:0046037) | 3.18817964 |
| 55 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.17594005 |
| 56 | proline biosynthetic process (GO:0006561) | 3.15603460 |
| 57 | vitamin transmembrane transport (GO:0035461) | 3.14377595 |
| 58 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.13587537 |
| 59 | aldehyde catabolic process (GO:0046185) | 3.10909441 |
| 60 | pyrimidine-containing compound salvage (GO:0008655) | 3.10760289 |
| 61 | pyrimidine nucleoside salvage (GO:0043097) | 3.10760289 |
| 62 | lysine metabolic process (GO:0006553) | 3.09953937 |
| 63 | lysine catabolic process (GO:0006554) | 3.09953937 |
| 64 | glucose catabolic process (GO:0006007) | 3.09114321 |
| 65 | GTP biosynthetic process (GO:0006183) | 3.07649877 |
| 66 | regulation of ligase activity (GO:0051340) | 3.06558936 |
| 67 | tricarboxylic acid metabolic process (GO:0072350) | 3.06038994 |
| 68 | regulation of cellular amine metabolic process (GO:0033238) | 3.05021052 |
| 69 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.04852198 |
| 70 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.01914178 |
| 71 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.01594682 |
| 72 | electron transport chain (GO:0022900) | 3.00642542 |
| 73 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.00621886 |
| 74 | respiratory electron transport chain (GO:0022904) | 3.00413245 |
| 75 | peptidyl-arginine methylation (GO:0018216) | 2.99453617 |
| 76 | peptidyl-arginine N-methylation (GO:0035246) | 2.99453617 |
| 77 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.96766247 |
| 78 | fructose metabolic process (GO:0006000) | 2.96120090 |
| 79 | oxaloacetate metabolic process (GO:0006107) | 2.95295383 |
| 80 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.93944024 |
| 81 | cellular metabolic compound salvage (GO:0043094) | 2.93274764 |
| 82 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.92574255 |
| 83 | establishment of protein localization to mitochondrion (GO:0072655) | 2.91924236 |
| 84 | UTP biosynthetic process (GO:0006228) | 2.91853266 |
| 85 | regulation of cholesterol metabolic process (GO:0090181) | 2.91091906 |
| 86 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.90706946 |
| 87 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.90232222 |
| 88 | negative regulation of protein ubiquitination (GO:0031397) | 2.89679519 |
| 89 | heme biosynthetic process (GO:0006783) | 2.87878723 |
| 90 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.87837452 |
| 91 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.86955281 |
| 92 | viral transcription (GO:0019083) | 2.86680888 |
| 93 | positive regulation of cell cycle arrest (GO:0071158) | 2.86674463 |
| 94 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.86278889 |
| 95 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.85654499 |
| 96 | L-methionine biosynthetic process (GO:0071265) | 2.85393634 |
| 97 | amino acid salvage (GO:0043102) | 2.85393634 |
| 98 | L-methionine salvage (GO:0071267) | 2.85393634 |
| 99 | base-excision repair, AP site formation (GO:0006285) | 2.85163701 |
| 100 | CTP biosynthetic process (GO:0006241) | 2.85141494 |
| 101 | CTP metabolic process (GO:0046036) | 2.85141494 |
| 102 | ubiquinone metabolic process (GO:0006743) | 2.84351057 |
| 103 | succinate metabolic process (GO:0006105) | 2.82833644 |
| 104 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.80868171 |
| 105 | histone arginine methylation (GO:0034969) | 2.80619231 |
| 106 | protein localization to mitochondrion (GO:0070585) | 2.79605502 |
| 107 | nucleotide salvage (GO:0043173) | 2.79594013 |
| 108 | protein retention in ER lumen (GO:0006621) | 2.79473033 |
| 109 | ethanol oxidation (GO:0006069) | 2.78254229 |
| 110 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.77531462 |
| 111 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.77208664 |
| 112 | deoxyribonucleotide catabolic process (GO:0009264) | 2.75593157 |
| 113 | deoxyribose phosphate catabolic process (GO:0046386) | 2.75536184 |
| 114 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.74983296 |
| 115 | glyoxylate metabolic process (GO:0046487) | 2.74617291 |
| 116 | branched-chain amino acid catabolic process (GO:0009083) | 2.73911345 |
| 117 | translational termination (GO:0006415) | 2.73774320 |
| 118 | NADP metabolic process (GO:0006739) | 2.73537762 |
| 119 | ribosomal small subunit assembly (GO:0000028) | 2.73179616 |
| 120 | primary alcohol catabolic process (GO:0034310) | 2.72988686 |
| 121 | fatty acid beta-oxidation (GO:0006635) | 2.72804975 |
| 122 | aromatic amino acid family catabolic process (GO:0009074) | 2.72697820 |
| 123 | regulation of proton transport (GO:0010155) | 2.72497379 |
| 124 | rRNA modification (GO:0000154) | 2.72458122 |
| 125 | translational elongation (GO:0006414) | 2.71715891 |
| 126 | monosaccharide biosynthetic process (GO:0046364) | 2.70631119 |
| 127 | heme transport (GO:0015886) | 2.70591560 |
| 128 | UTP metabolic process (GO:0046051) | 2.70196136 |
| 129 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.70049006 |
| 130 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.69552421 |
| 131 | bile acid and bile salt transport (GO:0015721) | 2.69344910 |
| 132 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.69048930 |
| 133 | de novo protein folding (GO:0006458) | 2.68939979 |
| 134 | deoxyribose phosphate metabolic process (GO:0019692) | 2.68716283 |
| 135 | kynurenine metabolic process (GO:0070189) | 2.68614375 |
| 136 | de novo posttranslational protein folding (GO:0051084) | 2.68358122 |
| 137 | purine nucleobase biosynthetic process (GO:0009113) | 2.68137318 |
| 138 | ribosome assembly (GO:0042255) | 2.67875313 |
| 139 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.67360915 |
| 140 | chaperone-mediated protein transport (GO:0072321) | 2.67266849 |
| 141 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.67210941 |
| 142 | serine family amino acid biosynthetic process (GO:0009070) | 2.66532725 |
| 143 | 2-oxoglutarate metabolic process (GO:0006103) | 2.65827932 |
| 144 | heme metabolic process (GO:0042168) | 2.65810419 |
| 145 | iron coordination entity transport (GO:1901678) | 2.64602932 |
| 146 | protein complex biogenesis (GO:0070271) | 2.64028910 |
| 147 | alpha-linolenic acid metabolic process (GO:0036109) | 2.63553082 |
| 148 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.62110069 |
| 149 | ADP metabolic process (GO:0046031) | 2.61821462 |
| 150 | hexose catabolic process (GO:0019320) | 2.61246983 |
| 151 | sulfur amino acid metabolic process (GO:0000096) | 2.60715447 |
| 152 | fatty acid oxidation (GO:0019395) | 2.60620112 |
| 153 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.60501648 |
| 154 | folic acid transport (GO:0015884) | 2.60352667 |
| 155 | ethanol metabolic process (GO:0006067) | 2.60012484 |
| 156 | amino-acid betaine metabolic process (GO:0006577) | 2.58826450 |
| 157 | lipid oxidation (GO:0034440) | 2.58663552 |
| 158 | branched-chain amino acid metabolic process (GO:0009081) | 2.58408776 |
| 159 | fatty acid catabolic process (GO:0009062) | 2.57949285 |
| 160 | purine-containing compound salvage (GO:0043101) | 2.56040754 |
| 161 | regulation of oxidative phosphorylation (GO:0002082) | 2.55835541 |
| 162 | regulation of histone phosphorylation (GO:0033127) | 2.55157926 |
| 163 | formation of translation preinitiation complex (GO:0001731) | 2.53045527 |
| 164 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.51432839 |
| 165 | acetyl-CoA metabolic process (GO:0006084) | 2.51124428 |
| 166 | proteasome assembly (GO:0043248) | 2.50820819 |
| 167 | negative regulation of ligase activity (GO:0051352) | 2.49817002 |
| 168 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.49817002 |
| 169 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.49752967 |
| 170 | hexose biosynthetic process (GO:0019319) | 2.49518486 |
| 171 | response to misfolded protein (GO:0051788) | 2.49108980 |
| 172 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.48668148 |
| 173 | cellular ketone body metabolic process (GO:0046950) | 2.47899863 |
| 174 | oxidoreduction coenzyme metabolic process (GO:0006733) | 2.47284282 |
| 175 | modified amino acid transport (GO:0072337) | 2.46924519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.44301485 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.19958506 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.00166560 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.03495344 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67639579 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.66896225 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.53089184 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.35697995 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.33337469 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.30436207 |
| 11 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.20892257 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.20399809 |
| 13 | * MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.10788072 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.09973256 |
| 15 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.08077125 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06563527 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98131771 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.96323032 |
| 19 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.93635592 |
| 20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.93410776 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.88552915 |
| 22 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.85957472 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.79260200 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78729020 |
| 25 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.73704007 |
| 26 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69213591 |
| 27 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.68869681 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67401381 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64628072 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63708309 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.63100794 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.61659177 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58732712 |
| 34 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.55466994 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55026270 |
| 36 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54608294 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54387528 |
| 38 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.53476882 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53178663 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.51822484 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49338248 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.49124341 |
| 43 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.48270305 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48216545 |
| 45 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47652987 |
| 46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.44689403 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43675932 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.43311900 |
| 49 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42148393 |
| 50 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42017180 |
| 51 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.41426266 |
| 52 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40853763 |
| 53 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.40328454 |
| 54 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39387896 |
| 55 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.39370187 |
| 56 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.39016950 |
| 57 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.38028875 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37941392 |
| 59 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.35021705 |
| 60 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33609940 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.33554874 |
| 62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32493111 |
| 63 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32072482 |
| 64 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31777925 |
| 65 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31660257 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30356294 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29911786 |
| 68 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29465473 |
| 69 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28981930 |
| 70 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.28012671 |
| 71 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27947881 |
| 72 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.27735427 |
| 73 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27202138 |
| 74 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.27184855 |
| 75 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27169657 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26948203 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25981986 |
| 78 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.25903939 |
| 79 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.25694707 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24824737 |
| 81 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.23579621 |
| 82 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21490743 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.21272995 |
| 84 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21059268 |
| 85 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20664589 |
| 86 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20087241 |
| 87 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18933383 |
| 88 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.18896463 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18653812 |
| 90 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18388743 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17674225 |
| 92 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.16182311 |
| 93 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16049308 |
| 94 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.15874302 |
| 95 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15639831 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14895913 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.14868313 |
| 98 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.14543011 |
| 99 | P68_20966046_ChIP-Seq_HELA_Human | 1.14324217 |
| 100 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.12366680 |
| 101 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.11799176 |
| 102 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11634381 |
| 103 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10854008 |
| 104 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.10160527 |
| 105 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.09565956 |
| 106 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08027043 |
| 107 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07828027 |
| 108 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.05892284 |
| 109 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.05406183 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05388127 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04663612 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02893545 |
| 113 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01559561 |
| 114 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.01331521 |
| 115 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00555543 |
| 116 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00496870 |
| 117 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00378151 |
| 118 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.99595727 |
| 119 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.99382877 |
| 120 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99323553 |
| 121 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.99073809 |
| 122 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98793856 |
| 123 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.98518991 |
| 124 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98272882 |
| 125 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.97584442 |
| 126 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97137076 |
| 127 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.96307539 |
| 128 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95355876 |
| 129 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95283806 |
| 130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95188039 |
| 131 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.95090716 |
| 132 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94410828 |
| 133 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94282191 |
| 134 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93859997 |
| 135 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.93529882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.86724380 |
| 2 | MP0005360_urolithiasis | 4.03387020 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.01106366 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 3.19114348 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.16577601 |
| 6 | MP0009840_abnormal_foam_cell | 3.11720525 |
| 7 | MP0002822_catalepsy | 2.92541682 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.76829327 |
| 9 | MP0005365_abnormal_bile_salt | 2.70248623 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.65034759 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.64061232 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.60837937 |
| 13 | MP0008058_abnormal_DNA_repair | 2.58996432 |
| 14 | MP0005083_abnormal_biliary_tract | 2.51959955 |
| 15 | MP0005332_abnormal_amino_acid | 2.46904280 |
| 16 | MP0003186_abnormal_redox_activity | 2.34556347 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.32935663 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.15910877 |
| 19 | MP0003111_abnormal_nucleus_morphology | 2.12223126 |
| 20 | MP0008932_abnormal_embryonic_tissue | 2.10801037 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.01777897 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.01452476 |
| 23 | MP0009643_abnormal_urine_homeostasis | 2.01237575 |
| 24 | MP0008007_abnormal_cellular_replicative | 1.99217084 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.93641278 |
| 26 | MP0004147_increased_porphyrin_level | 1.91116873 |
| 27 | MP0003786_premature_aging | 1.87870729 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 1.84421863 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 1.83055955 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.79220307 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.79068073 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.72365788 |
| 33 | MP0003011_delayed_dark_adaptation | 1.67190111 |
| 34 | MP0003329_amyloid_beta_deposits | 1.62817469 |
| 35 | MP0004858_abnormal_nervous_system | 1.61841796 |
| 36 | MP0001756_abnormal_urination | 1.59066606 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.58349511 |
| 38 | MP0003077_abnormal_cell_cycle | 1.58256184 |
| 39 | MP0009785_altered_susceptibility_to | 1.57323284 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.54874982 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.53461931 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.53330715 |
| 43 | MP0001764_abnormal_homeostasis | 1.46634856 |
| 44 | MP0000609_abnormal_liver_physiology | 1.35486720 |
| 45 | MP0004510_myositis | 1.34036227 |
| 46 | MP0000681_abnormal_thyroid_gland | 1.33837247 |
| 47 | MP0001727_abnormal_embryo_implantation | 1.33635439 |
| 48 | MP0003646_muscle_fatigue | 1.33218063 |
| 49 | MP0001873_stomach_inflammation | 1.30230861 |
| 50 | MP0005377_hearing/vestibular/ear_phenot | 1.30150629 |
| 51 | MP0003878_abnormal_ear_physiology | 1.30150629 |
| 52 | MP0006054_spinal_hemorrhage | 1.28784034 |
| 53 | MP0005623_abnormal_meninges_morphology | 1.27568957 |
| 54 | MP0002132_abnormal_respiratory_system | 1.25672891 |
| 55 | MP0000604_amyloidosis | 1.25028637 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.24538328 |
| 57 | MP0008872_abnormal_physiological_respon | 1.24509526 |
| 58 | MP0008260_abnormal_autophagy | 1.24433826 |
| 59 | MP0001661_extended_life_span | 1.23457790 |
| 60 | MP0003075_altered_response_to | 1.23077168 |
| 61 | MP0003303_peritoneal_inflammation | 1.21913959 |
| 62 | MP0005671_abnormal_response_to | 1.19903204 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.18399817 |
| 64 | MP0005501_abnormal_skin_physiology | 1.15665811 |
| 65 | MP0006082_CNS_inflammation | 1.15405536 |
| 66 | MP0005451_abnormal_body_composition | 1.14857185 |
| 67 | MP0010368_abnormal_lymphatic_system | 1.14253394 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.13937551 |
| 69 | MP0001243_abnormal_dermal_layer | 1.13527117 |
| 70 | MP0004130_abnormal_muscle_cell | 1.13504507 |
| 71 | MP0002254_reproductive_system_inflammat | 1.13504003 |
| 72 | MP0003724_increased_susceptibility_to | 1.13489841 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 1.13351477 |
| 74 | MP0000313_abnormal_cell_death | 1.12379329 |
| 75 | MP0004043_abnormal_pH_regulation | 1.11394095 |
| 76 | MP0000358_abnormal_cell_content/ | 1.11066574 |
| 77 | MP0002419_abnormal_innate_immunity | 1.10508870 |
| 78 | MP0002736_abnormal_nociception_after | 1.09644978 |
| 79 | MP0002723_abnormal_immune_serum | 1.09444389 |
| 80 | MP0008469_abnormal_protein_level | 1.08249745 |
| 81 | MP0001663_abnormal_digestive_system | 1.07537094 |
| 82 | MP0009697_abnormal_copulation | 1.07078215 |
| 83 | MP0001542_abnormal_bone_strength | 1.06892815 |
| 84 | MP0009763_increased_sensitivity_to | 1.06239384 |
| 85 | MP0005670_abnormal_white_adipose | 1.05945820 |
| 86 | MP0002733_abnormal_thermal_nociception | 1.05469166 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 1.03634482 |
| 88 | MP0003866_abnormal_defecation | 1.03547597 |
| 89 | MP0001765_abnormal_ion_homeostasis | 1.01869337 |
| 90 | MP0002722_abnormal_immune_system | 1.01609416 |
| 91 | MP0002420_abnormal_adaptive_immunity | 1.01443566 |
| 92 | MP0002429_abnormal_blood_cell | 1.01077829 |
| 93 | MP0002019_abnormal_tumor_incidence | 1.01003558 |
| 94 | MP0009333_abnormal_splenocyte_physiolog | 1.00432523 |
| 95 | MP0001819_abnormal_immune_cell | 0.98944160 |
| 96 | MP0002398_abnormal_bone_marrow | 0.98519700 |
| 97 | MP0003638_abnormal_response/metabolism_ | 0.98508684 |
| 98 | MP0000858_altered_metastatic_potential | 0.98258001 |
| 99 | MP0003195_calcinosis | 0.98112544 |
| 100 | MP0008873_increased_physiological_sensi | 0.96712626 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.96647173 |
| 102 | MP0005266_abnormal_metabolism | 0.96635105 |
| 103 | MP0008004_abnormal_stomach_pH | 0.95964124 |
| 104 | MP0005387_immune_system_phenotype | 0.95832082 |
| 105 | MP0001790_abnormal_immune_system | 0.95832082 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.95327235 |
| 107 | MP0005384_cellular_phenotype | 0.95284570 |
| 108 | MP0004947_skin_inflammation | 0.93898462 |
| 109 | MP0010030_abnormal_orbit_morphology | 0.93511355 |
| 110 | MP0000598_abnormal_liver_morphology | 0.93484006 |
| 111 | MP0001968_abnormal_touch/_nociception | 0.93284458 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.93233097 |
| 113 | MP0005376_homeostasis/metabolism_phenot | 0.93124709 |
| 114 | MP0008874_decreased_physiological_sensi | 0.92384083 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.91904018 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.91561002 |
| 117 | MP0003436_decreased_susceptibility_to | 0.90905226 |
| 118 | MP0001730_embryonic_growth_arrest | 0.90790576 |
| 119 | MP0001664_abnormal_digestion | 0.89870528 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.89799172 |
| 121 | MP0000490_abnormal_crypts_of | 0.89751592 |
| 122 | MP0000747_muscle_weakness | 0.89677544 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.88449213 |
| 124 | MP0001853_heart_inflammation | 0.87338710 |
| 125 | MP0009764_decreased_sensitivity_to | 0.86808820 |
| 126 | MP0003252_abnormal_bile_duct | 0.86366104 |
| 127 | MP0000716_abnormal_immune_system | 0.86293334 |
| 128 | MP0000685_abnormal_immune_system | 0.85766156 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.83964103 |
| 130 | MP0005464_abnormal_platelet_physiology | 0.82362804 |
| 131 | MP0001905_abnormal_dopamine_level | 0.81053043 |
| 132 | MP0003693_abnormal_embryo_hatching | 0.80711612 |
| 133 | MP0000350_abnormal_cell_proliferation | 0.79719515 |
| 134 | MP0005165_increased_susceptibility_to | 0.79346721 |
| 135 | MP0005410_abnormal_fertilization | 0.78548762 |
| 136 | MP0005397_hematopoietic_system_phenotyp | 0.78027613 |
| 137 | MP0001545_abnormal_hematopoietic_system | 0.78027613 |
| 138 | MP0005025_abnormal_response_to | 0.77229701 |
| 139 | MP0005166_decreased_susceptibility_to | 0.77054744 |
| 140 | MP0005621_abnormal_cell_physiology | 0.76684200 |
| 141 | MP0005381_digestive/alimentary_phenotyp | 0.76095909 |
| 142 | MP0001800_abnormal_humoral_immune | 0.75833665 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.75430247 |
| 144 | MP0002909_abnormal_adrenal_gland | 0.75035404 |
| 145 | MP0004957_abnormal_blastocyst_morpholog | 0.74027472 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.73692791 |
| 147 | MP0005535_abnormal_body_temperature | 0.71181639 |
| 148 | MP0000343_altered_response_to | 0.70831902 |
| 149 | MP0002138_abnormal_hepatobiliary_system | 0.69256104 |
| 150 | MP0001970_abnormal_pain_threshold | 0.68805133 |
| 151 | MP0001529_abnormal_vocalization | 0.66590881 |
| 152 | MP0000477_abnormal_intestine_morphology | 0.66520753 |
| 153 | MP0010155_abnormal_intestine_physiology | 0.64371241 |
| 154 | MP0009765_abnormal_xenobiotic_induced | 0.63406839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.15402653 |
| 2 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.15402653 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.86726777 |
| 4 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64545190 |
| 5 | Hepatic necrosis (HP:0002605) | 3.56763684 |
| 6 | Microvesicular hepatic steatosis (HP:0001414) | 3.52069404 |
| 7 | Malnutrition (HP:0004395) | 3.47248473 |
| 8 | Generalized aminoaciduria (HP:0002909) | 3.30960059 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.24145159 |
| 10 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.23544870 |
| 11 | Dicarboxylic aciduria (HP:0003215) | 3.23544870 |
| 12 | Xanthomatosis (HP:0000991) | 3.13432223 |
| 13 | Gout (HP:0001997) | 3.09257432 |
| 14 | Ragged-red muscle fibers (HP:0003200) | 3.01600241 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.00062799 |
| 16 | Oligomenorrhea (HP:0000876) | 2.99991435 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 2.99670959 |
| 18 | Hyperammonemia (HP:0001987) | 2.99180759 |
| 19 | Hyperglycinuria (HP:0003108) | 2.98986811 |
| 20 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.95234889 |
| 21 | Hepatosplenomegaly (HP:0001433) | 2.87064091 |
| 22 | Acute encephalopathy (HP:0006846) | 2.87031800 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.83787563 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 2.83787563 |
| 25 | Increased muscle lipid content (HP:0009058) | 2.77854570 |
| 26 | Abnormality of the anterior horn cell (HP:0006802) | 2.77455714 |
| 27 | Degeneration of anterior horn cells (HP:0002398) | 2.77455714 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.75498578 |
| 29 | Renal Fanconi syndrome (HP:0001994) | 2.75103605 |
| 30 | Hyperglycinemia (HP:0002154) | 2.74892578 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 2.73410129 |
| 32 | Mitochondrial inheritance (HP:0001427) | 2.73378255 |
| 33 | Lethargy (HP:0001254) | 2.69454773 |
| 34 | Testicular atrophy (HP:0000029) | 2.69180553 |
| 35 | Purpura (HP:0000979) | 2.65555148 |
| 36 | Abnormal protein glycosylation (HP:0012346) | 2.63808266 |
| 37 | Abnormal glycosylation (HP:0012345) | 2.63808266 |
| 38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.63808266 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.63808266 |
| 40 | Palpitations (HP:0001962) | 2.63308983 |
| 41 | Cholecystitis (HP:0001082) | 2.59968915 |
| 42 | Abnormal gallbladder physiology (HP:0012438) | 2.59968915 |
| 43 | Lactic acidosis (HP:0003128) | 2.57313257 |
| 44 | Vacuolated lymphocytes (HP:0001922) | 2.56855462 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.55042182 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.55042182 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.55042182 |
| 48 | Hyperlipoproteinemia (HP:0010980) | 2.53861584 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.53731002 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.50480200 |
| 51 | Cerebral edema (HP:0002181) | 2.50252154 |
| 52 | Ketosis (HP:0001946) | 2.47305921 |
| 53 | Increased CSF lactate (HP:0002490) | 2.42911336 |
| 54 | Loss of speech (HP:0002371) | 2.42538226 |
| 55 | Methylmalonic aciduria (HP:0012120) | 2.42474909 |
| 56 | Myoglobinuria (HP:0002913) | 2.40736378 |
| 57 | Increased intramyocellular lipid droplets (HP:0012240) | 2.40251390 |
| 58 | 3-Methylglutaconic aciduria (HP:0003535) | 2.39069008 |
| 59 | Multiple enchondromatosis (HP:0005701) | 2.38476704 |
| 60 | Spastic paraparesis (HP:0002313) | 2.38091752 |
| 61 | Nausea (HP:0002018) | 2.35805290 |
| 62 | Progressive neurologic deterioration (HP:0002344) | 2.34010631 |
| 63 | Vomiting (HP:0002013) | 2.32605387 |
| 64 | Rough bone trabeculation (HP:0100670) | 2.31906598 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.29786413 |
| 66 | Progressive muscle weakness (HP:0003323) | 2.29512589 |
| 67 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.27608050 |
| 68 | Hypokinesia (HP:0002375) | 2.27571209 |
| 69 | Intrahepatic cholestasis (HP:0001406) | 2.25884751 |
| 70 | Increased serum lactate (HP:0002151) | 2.23860521 |
| 71 | Delayed CNS myelination (HP:0002188) | 2.23692589 |
| 72 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.23551439 |
| 73 | Neuroendocrine neoplasm (HP:0100634) | 2.22626922 |
| 74 | Emotional lability (HP:0000712) | 2.21883633 |
| 75 | Irritability (HP:0000737) | 2.21589551 |
| 76 | Abnormality of the motor neurons (HP:0002450) | 2.21579212 |
| 77 | Abnormal neuron morphology (HP:0012757) | 2.21579212 |
| 78 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.21463513 |
| 79 | Axonal loss (HP:0003447) | 2.21323797 |
| 80 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20394382 |
| 81 | Hypobetalipoproteinemia (HP:0003563) | 2.20282154 |
| 82 | Increased hepatocellular lipid droplets (HP:0006565) | 2.20196113 |
| 83 | Cerebral palsy (HP:0100021) | 2.19596682 |
| 84 | Lipid accumulation in hepatocytes (HP:0006561) | 2.19553318 |
| 85 | Broad distal phalanx of finger (HP:0009836) | 2.19389157 |
| 86 | Respiratory failure (HP:0002878) | 2.16739231 |
| 87 | CNS demyelination (HP:0007305) | 2.15330726 |
| 88 | Brushfield spots (HP:0001088) | 2.13317242 |
| 89 | Abnormal number of erythroid precursors (HP:0012131) | 2.12118668 |
| 90 | Proximal tubulopathy (HP:0000114) | 2.11922468 |
| 91 | Cholelithiasis (HP:0001081) | 2.11806811 |
| 92 | Microretrognathia (HP:0000308) | 2.11627038 |
| 93 | Increased purine levels (HP:0004368) | 2.11457935 |
| 94 | Hyperuricemia (HP:0002149) | 2.11457935 |
| 95 | Hypertensive crisis (HP:0100735) | 2.09324189 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 2.06346895 |
| 97 | Prolonged neonatal jaundice (HP:0006579) | 2.05819001 |
| 98 | Abnormal gallbladder morphology (HP:0012437) | 2.05162597 |
| 99 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.05010449 |
| 100 | Increased serum pyruvate (HP:0003542) | 2.04159752 |
| 101 | Abnormality of glycolysis (HP:0004366) | 2.04159752 |
| 102 | Hyperbilirubinemia (HP:0002904) | 2.02737950 |
| 103 | Dysautonomia (HP:0002459) | 2.02361638 |
| 104 | Abnormal pupillary function (HP:0007686) | 2.02094104 |
| 105 | Late onset (HP:0003584) | 2.01234790 |
| 106 | Ketoacidosis (HP:0001993) | 2.00865283 |
| 107 | Vertebral compression fractures (HP:0002953) | 2.00463545 |
| 108 | Dry hair (HP:0011359) | 1.98296135 |
| 109 | Upper limb muscle weakness (HP:0003484) | 1.97786575 |
| 110 | Opisthotonus (HP:0002179) | 1.97374154 |
| 111 | Abnormality of the gallbladder (HP:0005264) | 1.97258162 |
| 112 | Increased IgM level (HP:0003496) | 1.97172450 |
| 113 | Abnormality of serum amino acid levels (HP:0003112) | 1.96041518 |
| 114 | Abnormality of nucleobase metabolism (HP:0010932) | 1.94713860 |
| 115 | Progressive macrocephaly (HP:0004481) | 1.94627404 |
| 116 | Glycosuria (HP:0003076) | 1.94408653 |
| 117 | Abnormality of urine glucose concentration (HP:0011016) | 1.94408653 |
| 118 | Aplastic anemia (HP:0001915) | 1.93910081 |
| 119 | Hypolipoproteinemia (HP:0010981) | 1.91995867 |
| 120 | Cerebral hypomyelination (HP:0006808) | 1.91990013 |
| 121 | Petechiae (HP:0000967) | 1.91970529 |
| 122 | Pancytopenia (HP:0001876) | 1.91503332 |
| 123 | Fasciculations (HP:0002380) | 1.91400867 |
| 124 | Increased serum ferritin (HP:0003281) | 1.90763816 |
| 125 | Growth hormone excess (HP:0000845) | 1.90644582 |
| 126 | Metabolic acidosis (HP:0001942) | 1.90303335 |
| 127 | Death in infancy (HP:0001522) | 1.90202570 |
| 128 | Abnormality of lateral ventricle (HP:0030047) | 1.89442866 |
| 129 | Esophageal neoplasm (HP:0100751) | 1.89436673 |
| 130 | Neoplasm of head and neck (HP:0012288) | 1.89436673 |
| 131 | Neonatal onset (HP:0003623) | 1.88349821 |
| 132 | Abnormal cartilage morphology (HP:0002763) | 1.87432926 |
| 133 | Rhabdomyolysis (HP:0003201) | 1.87152143 |
| 134 | Deep venous thrombosis (HP:0002625) | 1.87078460 |
| 135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86605901 |
| 136 | Exercise intolerance (HP:0003546) | 1.84943771 |
| 137 | Interstitial pulmonary disease (HP:0006530) | 1.83838092 |
| 138 | Abnormality of macrophages (HP:0004311) | 1.82819166 |
| 139 | Epiphyseal stippling (HP:0010655) | 1.82229335 |
| 140 | Progressive microcephaly (HP:0000253) | 1.81956646 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.81941969 |
| 142 | Increased cerebral lipofuscin (HP:0011813) | 1.81862929 |
| 143 | Delusions (HP:0000746) | 1.81777348 |
| 144 | Secondary amenorrhea (HP:0000869) | 1.80109193 |
| 145 | Exertional dyspnea (HP:0002875) | 1.79342272 |
| 146 | Postnatal microcephaly (HP:0005484) | 1.77660908 |
| 147 | Orthostatic hypotension (HP:0001278) | 1.77169494 |
| 148 | Panhypogammaglobulinemia (HP:0003139) | 1.76945430 |
| 149 | Acute hepatic failure (HP:0006554) | 1.76437449 |
| 150 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.76123056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.34156559 |
| 2 | VRK2 | 3.98538700 |
| 3 | BCKDK | 3.82943695 |
| 4 | KSR2 | 3.63241348 |
| 5 | MAP3K12 | 2.92608452 |
| 6 | NME2 | 2.90463506 |
| 7 | ARAF | 2.77910869 |
| 8 | BUB1 | 2.73629776 |
| 9 | ERN1 | 2.69320000 |
| 10 | MAP3K2 | 2.57044774 |
| 11 | TIE1 | 2.40960689 |
| 12 | PIK3CA | 2.32351787 |
| 13 | IRAK3 | 2.29962976 |
| 14 | CDK19 | 2.23670313 |
| 15 | KDR | 2.17191309 |
| 16 | PIM2 | 2.16066574 |
| 17 | MAP2K2 | 2.06856499 |
| 18 | NME1 | 2.03845645 |
| 19 | TRIB3 | 1.98577028 |
| 20 | MAP4K2 | 1.87616853 |
| 21 | TESK1 | 1.84888235 |
| 22 | MYLK | 1.82360358 |
| 23 | LMTK2 | 1.76468746 |
| 24 | EIF2AK1 | 1.76090658 |
| 25 | MAP2K1 | 1.67196197 |
| 26 | MAPKAPK3 | 1.63885941 |
| 27 | SRPK1 | 1.62357845 |
| 28 | VRK1 | 1.61500739 |
| 29 | NEK1 | 1.61062900 |
| 30 | MAP3K11 | 1.52288647 |
| 31 | TESK2 | 1.47546479 |
| 32 | SMG1 | 1.46790922 |
| 33 | MET | 1.43163309 |
| 34 | CSNK1G3 | 1.39824752 |
| 35 | CDK8 | 1.34925530 |
| 36 | SCYL2 | 1.34516730 |
| 37 | STK16 | 1.30829458 |
| 38 | LRRK2 | 1.28948321 |
| 39 | LIMK1 | 1.28042970 |
| 40 | DAPK2 | 1.19267036 |
| 41 | RPS6KB2 | 1.16919403 |
| 42 | SIK3 | 1.15069317 |
| 43 | DAPK3 | 1.10830914 |
| 44 | CSNK1A1L | 1.10769407 |
| 45 | BRAF | 1.10474049 |
| 46 | TRIM28 | 1.09420924 |
| 47 | PAK4 | 1.09325599 |
| 48 | ZAK | 1.08059345 |
| 49 | DAPK1 | 1.06772682 |
| 50 | TBK1 | 1.05857321 |
| 51 | GRK6 | 1.02846977 |
| 52 | MAP3K1 | 1.02576864 |
| 53 | WEE1 | 1.02449750 |
| 54 | CCNB1 | 1.02371414 |
| 55 | CAMKK2 | 1.01204098 |
| 56 | MAP3K3 | 0.98565740 |
| 57 | PRKG2 | 0.98248405 |
| 58 | MAP3K8 | 0.94809762 |
| 59 | MATK | 0.93585699 |
| 60 | PRKD3 | 0.92443770 |
| 61 | PDK3 | 0.91027614 |
| 62 | PDK4 | 0.91027614 |
| 63 | EPHA2 | 0.87010791 |
| 64 | ILK | 0.86677025 |
| 65 | TAOK2 | 0.84377423 |
| 66 | EIF2AK3 | 0.84107142 |
| 67 | CSNK1G2 | 0.82853107 |
| 68 | MAP2K7 | 0.82416191 |
| 69 | CSNK1G1 | 0.76798271 |
| 70 | EEF2K | 0.75854093 |
| 71 | FLT3 | 0.75241769 |
| 72 | FGFR4 | 0.74999899 |
| 73 | TSSK6 | 0.74682624 |
| 74 | ZAP70 | 0.73706990 |
| 75 | MAP2K6 | 0.73065837 |
| 76 | RAF1 | 0.72549175 |
| 77 | MAP4K1 | 0.71500909 |
| 78 | TGFBR1 | 0.71426912 |
| 79 | RPS6KA4 | 0.68592495 |
| 80 | RPS6KA5 | 0.68140784 |
| 81 | ACVR1B | 0.67846296 |
| 82 | PAK6 | 0.67384467 |
| 83 | PBK | 0.66294598 |
| 84 | ABL2 | 0.63768140 |
| 85 | BRSK1 | 0.62780378 |
| 86 | TLK1 | 0.60942410 |
| 87 | NTRK1 | 0.60509695 |
| 88 | GRK5 | 0.59990982 |
| 89 | TEC | 0.57826067 |
| 90 | CLK1 | 0.57232496 |
| 91 | MAPK11 | 0.55358927 |
| 92 | PAK1 | 0.54537078 |
| 93 | TYK2 | 0.53720952 |
| 94 | STK10 | 0.53590517 |
| 95 | PIK3CG | 0.52635129 |
| 96 | BRSK2 | 0.51800743 |
| 97 | CDK7 | 0.50925053 |
| 98 | IKBKB | 0.50016656 |
| 99 | PINK1 | 0.49464221 |
| 100 | MAP3K5 | 0.49410894 |
| 101 | PLK3 | 0.47210538 |
| 102 | PRPF4B | 0.45936540 |
| 103 | AURKA | 0.44533099 |
| 104 | FES | 0.44355254 |
| 105 | BMX | 0.43556642 |
| 106 | PDK2 | 0.41494432 |
| 107 | MAP2K3 | 0.39605062 |
| 108 | AURKB | 0.39148151 |
| 109 | ATR | 0.38711936 |
| 110 | TTK | 0.38493010 |
| 111 | CDK14 | 0.38308506 |
| 112 | PLK1 | 0.38144353 |
| 113 | TNK2 | 0.37269772 |
| 114 | MOS | 0.36476544 |
| 115 | BMPR1B | 0.36306451 |
| 116 | JAK2 | 0.36228886 |
| 117 | BTK | 0.36014228 |
| 118 | AKT2 | 0.35915286 |
| 119 | MAPKAPK5 | 0.35025658 |
| 120 | STK4 | 0.33772791 |
| 121 | CDK11A | 0.33288498 |
| 122 | MAPKAPK2 | 0.32367383 |
| 123 | DYRK2 | 0.32102179 |
| 124 | MAP3K9 | 0.31904371 |
| 125 | PHKG2 | 0.31230945 |
| 126 | PHKG1 | 0.31230945 |
| 127 | CAMK2G | 0.30319310 |
| 128 | CAMK1 | 0.30052885 |
| 129 | CDK15 | 0.29822053 |
| 130 | OXSR1 | 0.29463790 |
| 131 | EIF2AK2 | 0.29039019 |
| 132 | PRKCD | 0.28416886 |
| 133 | ADRBK1 | 0.28321431 |
| 134 | EPHB1 | 0.27632059 |
| 135 | CDK18 | 0.27422584 |
| 136 | PRKCI | 0.27390268 |
| 137 | RIPK4 | 0.27045835 |
| 138 | CAMK2D | 0.26891957 |
| 139 | KIT | 0.26387724 |
| 140 | MINK1 | 0.26015782 |
| 141 | MST4 | 0.23196013 |
| 142 | PDPK1 | 0.20528850 |
| 143 | RET | 0.19881071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.16416815 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.99081591 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.82217248 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.65370908 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.45805936 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.37767691 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34139080 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.21138826 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.18976553 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.18827081 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15177823 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06571335 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.02072767 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.00859809 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.00594069 |
| 16 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.99874738 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94273107 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.93561090 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.92806584 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.92005367 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.89536879 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.89088401 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.84154621 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80697850 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.74843940 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.73101715 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65689355 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64488758 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.57319786 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49394734 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.45686207 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.43919648 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41698541 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.40379933 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38939919 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.38831273 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37893232 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37483788 |
| 39 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.37117407 |
| 40 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.36052960 |
| 41 | Galactose metabolism_Homo sapiens_hsa00052 | 1.35263705 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35052527 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34683477 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31486418 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30763586 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.30743518 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.30273269 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.29978714 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24381726 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24289074 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20871834 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.20544444 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18608897 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16957340 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15743249 |
| 56 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.13836720 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13727907 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12717161 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11417389 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08467908 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08290507 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07647118 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07616441 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.04700056 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04290256 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00866685 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.00746803 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98864718 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96868507 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.95676233 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91074576 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89274021 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89004799 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88774784 |
| 75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.85945694 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.84572776 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83617215 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82526327 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80360563 |
| 80 | RNA transport_Homo sapiens_hsa03013 | 0.75237911 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74899319 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74318039 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73540353 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73453858 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70430605 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69656790 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.69395095 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.69109362 |
| 89 | RNA polymerase_Homo sapiens_hsa03020 | 0.67538635 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.67283078 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66317662 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65624773 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63333938 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62832382 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62654987 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59362824 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57079082 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.54582383 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53958875 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.53695976 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.53322267 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52442351 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52013806 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.50870359 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.46027000 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45350426 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45288217 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45279892 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45123350 |
| 110 | Cell cycle_Homo sapiens_hsa04110 | 0.44965785 |
| 111 | DNA replication_Homo sapiens_hsa03030 | 0.43799801 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43043970 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42969904 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.40111093 |
| 115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39345885 |
| 116 | Base excision repair_Homo sapiens_hsa03410 | 0.38918131 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38504445 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38466752 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.38114073 |
| 120 | Purine metabolism_Homo sapiens_hsa00230 | 0.37732975 |
| 121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36483691 |
| 122 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35320771 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34812344 |
| 124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.34799685 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34546044 |
| 126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34199486 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.34053019 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.32272211 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30049131 |
| 130 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29915569 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.29131871 |
| 132 | Protein export_Homo sapiens_hsa03060 | 0.27220457 |
| 133 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25409776 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.24818772 |
| 135 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.20740223 |
| 136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19202802 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15156570 |

